Studies show NSAIDs, including naproxen, may increase risk of acute MI
نویسندگان
چکیده
منابع مشابه
Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradox.
Angiotensin-converting enzyme inhibitors (ACEIs) play an important role in the management of patients at increased cardiovascular (CV) risk. ACEIs reduce both myocardial infarction (MI) and mortality in patients with symptomatic congestive heart failure or asymptomatic left ventricular dysfunction,1 as evidenced by a class I recommendation in the American College of Cardiology (ACC)/American He...
متن کاملCOPD May Increase Mortality Risks For MI Patients
S A N D I E G O — Smokingrelated cell damage may leave molecular footprints in saliva and oral epithelial cells, offering the potential for noninvasive early diagnosis of lung cancer and of head and neck cancers, researchers reported in separate studies at the annual meeting of the American Association for Cancer Research. “When people smoke cigarettes, the whole field is exposed to carcinogens...
متن کاملInsomnia may raise risk of MI and stroke, review finds.
Insomnia is associated with increased risk of future myocardial infarction (MI) and stroke, a meta-analysis of prospective cohort studies has found. Insomnia—characterised by difficulty initiating or maintaining sleep, early morning waking, or non-restorative sleep—is common, as studies show that it affects around one in three adults. Sleep problems have previously been associated with cardiova...
متن کاملDo angiotensin receptor blockers increase the risk of myocardial infarction? Angiotensin Receptor Blockers May Increase Risk of Myocardial Infarction Unraveling the ARB-MI Paradox
Angiotensin-converting enzyme inhibitors (ACEIs) play an important role in the management of patients at increased cardiovascular (CV) risk. ACEIs reduce both myocardial infarction (MI) and mortality in patients with symptomatic congestive heart failure or asymptomatic left ventricular dysfunction,1 as evidenced by a class I recommendation in the American College of Cardiology (ACC)/American He...
متن کاملReview: Selective COX 2 inhibitors increase vascular events more than placebo and naproxen but not more than other NSAIDs.
M e t h o d s Data sources: MEDLINE and EMBASE/ Excerpta Medica (1966 to April 2005), U.S. Food and Drug Administration Web site, and drug manufacturers. Study selection and assessment: Randomized controlled trials (RCTs) ≥ 4 weeks in duration that compared a selective COX2 inhibitor with placebo or a traditional NSAID. 138 RCTs (n = 145 373) met the selection criteria. Investigators and manufa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pharmacy Today
سال: 2017
ISSN: 1042-0991
DOI: 10.1016/j.ptdy.2017.06.024